Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by AIDS Malignancy Consortium
Sponsor:
Collaborators:
National Cancer Institute (NCI)
The EMMES Corporation
University of Arkansas
Information provided by (Responsible Party):
AIDS Malignancy Consortium
ClinicalTrials.gov Identifier:
NCT02059499
First received: February 7, 2014
Last updated: September 1, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2018
  Estimated Primary Completion Date: September 2017 (Final data collection date for primary outcome measure)